Document is current
Any future updates will be listed below
-
Authors
Rezk, Mamdouh R. https://orcid.org/0000-0002-4425-4390
Badr, Kamal A.
Hosny, Ahmed Abd El Hamid
Abdel Magid, Aya M. https://orcid.org/0000-0001-6175-1690
-
Funding
Funding for this research was provided by:
Atco Pharma for Pharmaceutical Industries, Egypt
Cairo University
- License Information
-
More Information
Article History
Received: 13 August 2025
Accepted: 14 January 2026
First Online: 14 February 2026
Declarations
:
: The study protocol was approved by the Independent Ethics Committee (IEC) of ARC. The ClinicalTrials.gov registration number is NCT07121868 , retrospectively registered on August 13, 2025. All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional committee, the Guidelines for Good Clinical Practice of the International Conference on Harmonisation, and the Helsinki Declaration and its later amendments (2013) or comparable ethical standards. Written informed consent was obtained from all participants prior to the initiation of the study procedures. The form was explained to all participants before signing it so that the nature, purpose, benefits and potential risks of the study were understood.
: Ahmed Abd El Hamid Hosny is an employee of Atco Pharma for Pharmaceutical Industries, Egypt, which sponsored the study. The remaining authors declare that they have no competing interests regarding the content of this article.
